News
ALC
79.19
+0.49%
0.39
SI-Bone added to ‘Conviction List’, named ‘2026 Top Pick’ at Needham
TipRanks · 12h ago
Broadwood Partners Slams Alcon–STAAR Deal, Flag Sale Process Concerns
Benzinga · 12h ago
STAAR Surgical Faces Shareholder Backlash Over Proposed Sale to Alcon
Reuters · 13h ago
STAAR Surgical gains as proxy adviser ISS supports revised Alcon deal
Seeking Alpha · 1d ago
ISS urges Staar Surgical shareholders to vote for Alcon merger
TipRanks · 1d ago
STAAR Shareholders Urged to Approve $30.75-Per-Share Alcon Deal
Reuters · 1d ago
Weekly Report: what happened at ALC last week (1208-1212)?
Weekly Report · 1d ago
Catalyst Watch: Economic data flurry, Micron earnings, and triple-witching day
Seeking Alpha · 4d ago
Buy/Sell: Wall Street’s top 10 stock calls this week
TipRanks · 4d ago
STAAR Surgical falls as proxy adviser recommends against revised Alcon deal
Seeking Alpha · 4d ago
Glass Lewis Recommends STAAR Surgical Shareholders Reject Alcon Acquisition
Reuters · 4d ago
Barclays Sticks to Their Hold Rating for Alcon (ALC)
TipRanks · 4d ago
Midday Fly By: Disney invests $1B in OpenAI, Oracle reports mixed Q2
TipRanks · 5d ago
Alcon draws double downgrade at BofA on earnings growth risk
Seeking Alpha · 5d ago
Staar Surgical comments on ‘misinformation’ regarding go-shop process
TipRanks · 5d ago
PayPal downgraded, Roku upgraded: Wall Street’s top analyst calls
TipRanks · 5d ago
Staar Surgical shareholder issues statement on acquisition by Alcon
TipRanks · 5d ago
Broadwood Slams STAAR–Alcon Deal as Flawed and Unfair to Shareholders
Benzinga · 5d ago
Alcon Cut to Underperform From Buy by B of A Securities
Dow Jones · 5d ago
Alcon Price Target Cut to $75.00/Share From $100.00 by B of A Securities
Dow Jones · 5d ago
More
Webull provides a variety of real-time ALC stock news. You can receive the latest news about Alcon Inc through multiple platforms. This information may help you make smarter investment decisions.
About ALC
Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes implantables, consumables and surgical equipment required for these procedures and supports the end-to-end needs of the ophthalmic surgeon. The Company’s Vision Care business comprises of daily disposable, reusable and color-enhancing contact lenses and a portfolio of ocular health products, including products for dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The Company operates in 60 countries and serves consumers and patients in over 140 countries.